Wells Fargo & Company »

Recursion Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $512k 52k 9.86
2023-09-30 $1.9M 245k 7.65
2023-06-30 $846k 113k 7.47
2022-12-31 $16k 2.0k 7.71
2022-09-30 $20k 1.7k 11.55
2022-06-30 $12k 1.4k 8.47
2022-03-31 $72k 10k 7.11
2021-12-31 $868k 51k 17.14
2021-09-30 $0 13 0.00